How we rank research peptide vendors.

What we evaluate

Every vendor included in our rankings is evaluated against seven weighted criteria. We compile the data exclusively from publicly accessible sources — vendor websites, public Certificate of Analysis archives, published Trustpilot and review-platform scores, and where available, the vendor's own published shipping and payment policies.

1. Catalog depth and SKU count. How many distinct compounds are offered, and at what tier of breadth versus the rest of the market.
2. Format diversity. Lyophilized vials only, or vials plus pens, capsules, blends, kits, sprays, and oral liquids? Format breadth materially affects research-use flexibility.
3. Analytical documentation. Does the vendor publish a Certificate of Analysis for every batch? Is documentation per-vial via QR code, or batch-level via PDF, or available only by support request?
4. Lab testing scope. The full analytical panel applied — HPLC purity, mass spectrometry for identity confirmation, LAL endotoxin, sterility, and ICP-MS heavy metals. Vendors that publish HPLC only score lower than those publishing all five.
5. Shipping logistics. US-domestic origin clarity, named same-day or next-day dispatch cutoff, lyophilized ambient stability windows, and whether insulated packaging is included where temperature-sensitive.
6. Payment flexibility. Number of distinct payment methods accepted — card, Bitcoin, Ethereum, wire transfer, paper check, and other crypto. Vendors with five-method support score above card-only checkouts.
7. Pricing transparency. Whether the vendor publishes per-mg pricing, quantity tiers, and whether quoted prices reconcile cleanly across published comparison tables.

How we score

Each vendor receives a composite score on a 7.0–9.9 scale. The top tier (9.4–9.9) is reserved for vendors that meet a high bar on a majority of the seven criteria and have no material gap on any single criterion. The mid tier (8.0–9.3) covers vendors with documented strengths and a clear, identifiable trade-off. The lower band (7.0–7.9) captures vendors with one or more significant constraints — narrow catalogs, restricted access models, or documentation gaps.

Why we cap scores at 9.9 and never assign a 10. No vendor is perfect. Every vendor we have evaluated has at least one area where its public offering could be more transparent, where documentation could be more granular, or where pricing could better reconcile to peer benchmarks. Capping the top of the scale at 9.9 enforces analytical humility and avoids treating any vendor as beyond editorial scrutiny.

Our research process

For every vendor included, we read the public-facing website in full — catalog pages, individual product pages, shipping and payment policies, Terms of Service, and any published Certificate of Analysis archives. Where a vendor maintains a public Lab Hub, we sample CoAs across compounds and batches to assess analytical panel scope and consistency. Where the vendor publishes purity floors or analytical standards, we compare those claims against the corresponding CoA data on file.

For payment methods, we walk the checkout flow as far as the payment-selection step to verify the methods listed. For shipping, we capture the named same-day cutoff (if any), the publicly stated dispatch policy, and the lyophilized ambient-stability window where the vendor publishes one.

We do not conduct in-laboratory re-verification of vendor product. Our scoring weighs documentation transparency — what a vendor publishes, how it organises that documentation, and whether the published claims are internally consistent — rather than independent chemical re-analysis of physical product. This is an explicit scope limitation: we evaluate documentation architecture, not in-house analytical confirmation.

What we do not evaluate

We do not test peptides in our own laboratory. We do not assess therapeutic efficacy, clinical safety, or human-use suitability — research peptides are for research use only and not for human consumption. We do not rank vendors on legal, regulatory, or jurisdictional grounds beyond what each vendor publicly discloses about its operating address and corporate domicile.

Update cadence

Rankings are formally reviewed quarterly. The "Updated" date on each article reflects the most recent editorial pass. Where a vendor's catalog, pricing, payment options, or documentation architecture changes materially between scheduled reviews, we may publish an interim revision noted at the top of the relevant article.

Disclaimer

All vendor evaluations are based on publicly available information as of the publication date. Vendor offerings change frequently — pricing, SKUs, payment methods, and shipping policies are subject to revision by vendors at any time. Research peptides are for research use only and not for human consumption. Best Research Peptide Guide does not accept paid placements, sponsorships, or commissions from vendors reviewed.